How to read an Indian listed company's Audit Committee disclosure in 5 minutes — composition, financial-literacy, meeting-cadence, attendance and terms-of-reference tests, illustrated with Titan Biotech FY25 audited governance markers.
William Thorndike's 2012 study of eight outsider CEOs revealed that compounding shareholder wealth is a capital-allocation discipline — not an operating one. Titan Biotech's FY25 audited numbers fit the five-choice template.
Tversky & Kahneman's 1983 conjunction fallacy explains why Indian retail investors judge five-leg bull stories as more probable than one-leg theses — and how single-leg corporate behaviour like Titan Biotech Ltd's audited FY25 numbers illustrates the opposite discipline.